Current status of ribozymes as gene therapy agents for cancer.
about
Ribozyme-mediated REV1 inhibition reduces the frequency of UV-induced mutations in the human HPRT geneCatalytic nucleic acid enzymes for the study and development of therapies in the central nervous system: Review Article.Therapeutic regulation of gene expression in the inner ear using RNA interference.
P2860
Current status of ribozymes as gene therapy agents for cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Current status of ribozymes as gene therapy agents for cancer.
@ast
Current status of ribozymes as gene therapy agents for cancer.
@en
Current status of ribozymes as gene therapy agents for cancer.
@nl
type
label
Current status of ribozymes as gene therapy agents for cancer.
@ast
Current status of ribozymes as gene therapy agents for cancer.
@en
Current status of ribozymes as gene therapy agents for cancer.
@nl
prefLabel
Current status of ribozymes as gene therapy agents for cancer.
@ast
Current status of ribozymes as gene therapy agents for cancer.
@en
Current status of ribozymes as gene therapy agents for cancer.
@nl
P2860
P356
P1433
P1476
Current status of ribozymes as gene therapy agents for cancer.
@en
P2093
P2860
P304
P356
10.1081/CNV-100103848
P577
2001-01-01T00:00:00Z